Articles and posts USelectAllNewsRebel Bites podcast invites Neola Medical’s CEO Hanna SjöströmOctober 23, 2023 | NewsBioStock interviews CEO Hanna Sjöström directly from Palo Alto, USA, to hear more about the latest clinical study results and the support from StanfordOctober 19, 2023 | NewsNyhetsbyrån Direct in live interview with CEO Hanna SjöströmOctober 19, 2023 | NewsCEO Hanna Sjöström participates in this year’s Stanford Impact1 CEO SummitOctober 18, 2023 | NewsStanford selects Neola Medical’s medical technology product as an important innovation for neonatal care and gives the company support to market launch through the exclusive program Impact1October 12, 2023 | News, Non regulatoryNew successful results from clinical study on 100 newborn babies with Neola Medical’s medical deviceOctober 10, 2023 | News, Non regulatoryHanna Sjöström’s captivating investor presentation at the Redeye Medtech SeminarSeptember 28, 2023 | News, PresentationsCEO Hanna Sjöström comments Q2 report 2023 in new article by BioStockAugust 17, 2023 | NewsNeola Medical AB appoints ABG Sundal Collier as liquidity providerAugust 17, 2023 | News, RegulatoryCEO and CFO presents Q2 2023August 16, 2023 | News, PresentationsNeola Medical Q2 report 2023 – Intensified work in the market preparations before launch in the U.S.August 15, 2023 | News, RegulatoryNeola Medicals trademark has been registered in the U.S.August 8, 2023 | News, Non regulatory# 12345678910111213 $ For InvestorsWe are on a journey to revolutionize neonatal intensive careLearn more about investing in Neola Medical Join our journey
BioStock interviews CEO Hanna Sjöström directly from Palo Alto, USA, to hear more about the latest clinical study results and the support from StanfordOctober 19, 2023 | News
Stanford selects Neola Medical’s medical technology product as an important innovation for neonatal care and gives the company support to market launch through the exclusive program Impact1October 12, 2023 | News, Non regulatory
New successful results from clinical study on 100 newborn babies with Neola Medical’s medical deviceOctober 10, 2023 | News, Non regulatory
Hanna Sjöström’s captivating investor presentation at the Redeye Medtech SeminarSeptember 28, 2023 | News, Presentations
Neola Medical Q2 report 2023 – Intensified work in the market preparations before launch in the U.S.August 15, 2023 | News, Regulatory